[1]
|
Hinchey, J., Chaves, C., Appignani, B., et al. (1996) A Reversible Posterior Leukoencephalopathy Syndrome. The New England Journal of Medicine, 334, 494-500. https://doi.org/10.1056/NEJM199602223340803
|
[2]
|
Li, K., Yang, Y., Guo, D., et al. (2020) Clinical and MRI Features of Posterior Reversible Encephalopathy Syndrome with Atypical Regions: A Descriptive Study with a Large Sample Size. Frontiers in Neurology, 11, Article No. 194.
https://doi.org/10.3389/fneur.2020.00194
|
[3]
|
Granata, G., Greco, A., Iannella, G., et al. (2015) Posterior Reversi-ble Encephalopathy Syndrome—Insight into Pathogenesis, Clinical Variants and Treatment Approaches. Autoimmunity Reviews, 14, 830-836.
https://doi.org/10.1016/j.autrev.2015.05.006
|
[4]
|
Cui, H., Lei, R. and Zhang, B. (2022) Clinical Features and Risk Factors of Mortality in Patients with Posterior Reversible Encephalopathy Syndrome. Behavioural Neurology, 2022, Ar-ticle ID: 9401661.
https://doi.org/10.1155/2022/9401661
|
[5]
|
Legriel, S., Schraub, O., Azoulay, E., et al. (2012) Determinants of Recovery from Severe Posterior Reversible Encephalopathy Syndrome. PLOS ONE, 7, e44534. https://doi.org/10.1371/journal.pone.0044534
|
[6]
|
Chen, T. (2020) Childhood Posterior Reversible Encephalopathy Syndrome: Clinicoradiological Characteristics, Managements, and Outcome. Frontiers in Pediatrics, 8, Article No. 585. https://doi.org/10.3389/fped.2020.00585
|
[7]
|
Ghali, M.G.Z., Davanzo, J., Leo, M., et al. (2019) Posterior Reversi-ble Encephalopathy Syndrome in Pediatric Patients: Pathophysiology, Diagnosis, and Management. Leukemia & Lym-phoma, 60, 2365-2372.
https://doi.org/10.1080/10428194.2019.1594210
|
[8]
|
Alhilali, L.M., Reynolds, A.R. and Fakhran, S. (2014) A Multi-Disciplinary Model of Risk Factors for Fatal Outcome in Posterior Reversible Encephalopathy Syndrome. Journal of the Neurological Sciences, 347, 59-65.
https://doi.org/10.1016/j.jns.2014.09.019
|
[9]
|
Thavamani, A., Umapathi, K.K., Puliyel, M., et al. (2020) Epidemi-ology, Comorbidities, and Outcomes of Posterior Reversible Encephalopathy Syndrome in Children in the United States. Pediatric Neurology, 103, 21-26.
https://doi.org/10.1016/j.pediatrneurol.2019.07.007
|
[10]
|
Fischer, M. and Schmutzhard, E. (2017) Posterior Re-versible Encephalopathy Syndrome. Journal of Neurology, 264, 1608-1616. https://doi.org/10.1007/s00415-016-8377-8
|
[11]
|
Raj, S., Overby, P., Erdfarb, A., et al. (2013) Posterior Reversible Encephalopathy Syndrome: Incidence and Associated Factors in a Pediatric Critical Care Population. Pediatric Neurology, 49, 335-339.
https://doi.org/10.1016/j.pediatrneurol.2013.06.007
|
[12]
|
Khan, R.B., Sadighi, Z.S., Zabrowski, J., et al. (2016) Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome during Childhood Cancer Treatment. Pediatric Blood & Cancer, 63, 523-526.
https://doi.org/10.1002/pbc.25790
|
[13]
|
Virojtriratana, T., Hongsawong, N., Wiwattanadittakul, N., et al. (2022) Comparison of Clinical Manifestations, Laboratory, Neuroimaging Findings, and Outcomes in Children with Posterior Reversible Encephalopathy Syndrome (PRES) in Children with and without Renal Disease. Pediatric Neurology, 134, 37-44.
https://doi.org/10.1016/j.pediatrneurol.2022.06.012
|
[14]
|
Damrongpipatkul, U., Oranratanachai, K., Kasitanon, N., et al. (2018) Clinical Features, Outcome, and Associated Factors for Posterior Reversible Encephalopathy in Thai Patients with Systemic Lupus Erythematosus: A Case-Control Study. Clinical Rheumatology, 37, 691-702. https://doi.org/10.1007/s10067-017-3892-2
|
[15]
|
Barber, C.E., Leclerc, R., Gladman, D.D., et al. (2011) Posterior Reversible Encephalopathy Syndrome: An Emerging Disease Manifestation in Systemic Lupus Erythematosus. Seminars in Arthritis and Rheumatism, 41, 353-363.
https://doi.org/10.1016/j.semarthrit.2011.07.001
|
[16]
|
Schmiegelow, K., Attarbaschi, A., Barzilai, S., et al. (2016) Consensus Definitions of 14 Severe Acute Toxic Effects for Childhood Lymphoblastic Leukaemia Treatment: A Delphi Consensus. The Lancet Oncology, 17, e231-e239.
https://doi.org/10.1016/S1470-2045(16)30035-3
|
[17]
|
Fugate, J.E., Claassen, D.O., Cloft, H.J., et al. (2010) Poste-rior Reversible Encephalopathy Syndrome: Associated Clinical and Radiologic Findings. Mayo Clinic Proceedings, 85, 427-432. https://doi.org/10.4065/mcp.2009.0590
|
[18]
|
Ishimori, M.L., Pressman, B.D., Wallace, D.J., et al. (2007) Posterior Reversible Encephalopathy Syndrome: Another Manifestation of CNS SLE? Lupus, 16, 436-443. https://doi.org/10.1177/0961203307078682
|
[19]
|
Fugate, J.E. and Rabinstein, A.A. (2015) Posterior Reversible Encephalopathy Syndrome: Clinical and Radiological Manifestations, Pathophysiology, and Outstanding Questions. The Lancet Neurology, 14, 914-925.
https://doi.org/10.1016/S1474-4422(15)00111-8
|
[20]
|
Ando, Y., Ono, Y., Sano, A., et al. (2022) Posterior Re-versible Encephalopathy Syndrome: A Review of the Literature. Internal Medicine, 61, 135-141. https://doi.org/10.2169/internalmedicine.7520-21
|
[21]
|
Bartynski, W.S. (2008) Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema. American Journal of Neuroradi-ology, 29, 1043-1049. https://doi.org/10.3174/ajnr.A0929
|
[22]
|
Singhi, P., Subramanian, C., Jain, V., et al. (2002) Reversible Brain Lesions in Childhood Hypertension. Acta Paediatrica, 91, 1005-1007. https://doi.org/10.1111/j.1651-2227.2002.tb02893.x
|
[23]
|
Forteza, A., Echeverria, Y., Haussen, D.C., et al. (2010) Cerebral Vasomotor Reactivity Monitoring in Posterior Reversible Encephalopathy Syndrome. BMJ Case Reports, 2010, bcr10-bcr2009.
https://doi.org/10.1136/bcr.10.2009.2345
|
[24]
|
Valdez-López, M., Aguirre-Aguilar, E., Valdés-Ferrer, S.I., et al. (2021) Posterior Reversible Encephalopathy Syndrome: A Neuropsychiatric Manifestation of Systemic Lupus Erythe-matosus. Autoimmunity Reviews, 20, Article ID: 102739. https://doi.org/10.1016/j.autrev.2020.102739
|
[25]
|
Bartynski, W.S. and Boardman, J.F. (2008) Catheter Angi-ography, MR Angiography, and MR Perfusion in Posterior Reversible Encephalopathy Syndrome. American Journal of Neuroradiology, 29, 447-455.
https://doi.org/10.3174/ajnr.A0839
|
[26]
|
Potter, T. and Schaefer, T.J. (2023) Hypertensive Encephalopa-thy.
|
[27]
|
Hu, M.H., Wang, H.S., Lin, K.L., et al. (2008) Clinical Experience of Childhood Hypertensive Encephalopathy over an Eight Year Period. Chang Gung Medical Journal, 31, 153-158.
|
[28]
|
Amberg, G.C. and Navedo, M.F. (2013) Calcium Dynamics in Vascular Smooth Muscle. Microcirculation, 20, 281-289. https://doi.org/10.1111/micc.12046
|
[29]
|
Zamponi, G.W., Striessnig, J., Koschak, A., et al. (2015) The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential. Pharmaco-logical Reviews, 67, 821-870.
https://doi.org/10.1124/pr.114.009654
|
[30]
|
Czosnyka, M., Smielewski, P., Kirkpatrick, P., et al. (1998) Continu-ous Monitoring of Cerebrovascular Pressure-Reactivity in Head Injury. Proceedings of the 10th International ICP Sym-posium, Williamsburg, 25-29 May 1997, 74-77. https://doi.org/10.1007/978-3-7091-6475-4_23
|
[31]
|
Budohoski, K.P., Czosnyka, M., Kirkpatrick, P.J., et al. (2013) Clinical Relevance of Cerebral Autoregulation Following Subarach-noid Haemorrhage. Nature Reviews Neurology, 9, 152-163. https://doi.org/10.1038/nrneurol.2013.11
|